Latest ovarian cancer Stories

-- Surgeons Honored for Advances in Mastectomy Breast Reconstruction -- TARRYTOWN, N.Y., April 11, 2013 /PRNewswire/ -- Plastic and reconstructive surgeons Dr. C. Andrew Salzberg and Dr. R. Michael Koch of the New York Group for Plastic Surgery are spearheading a fundraising campaign to benefit FORCE (Facing Our Risk of Cancer Empowered), the only national nonprofit organization devoted to supporting women at hereditary risk for various cancers, including breast cancer. Dr....

New Pre-Clinical Data Presented at AACR Annual Meeting in Washington, DC SAN DIEGO, April 10, 2013 /PRNewswire/ -- MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced the presentation of new data showing the ability of its mitochondrial inhibitor drug candidate, ME-344, to decrease tumor burden and delay recurrence in a pre-clinical in vivo model of recurrent epithelial ovarian cancer, the most lethal of...

New Data Describes the Efficacy of NovoTTF(TM) Therapy in Combination with Chemotherapy in Preclinical Solid Tumor Models WASHINGTON, April 10, 2013 /PRNewswire/ -- Novocure announced today that new data from preclinical testing of NovoTTF Therapy in non-small cell lung carcinoma (NSCLC), ovarian and pancreatic cancer has been presented at the 2013 AACR Annual Meeting. The new data builds on existing published research describing the potential efficacy of NovoTTF Therapy in a wide...

Most decorated gymnast in U.S. history partners with the national nonprofit to promote awareness of ovarian cancer. Brookside, New Jersey (PRWEB) April 02, 2013 Turn The Towns Teal, a national nonprofit dedicated to promoting awareness of ovarian cancer and its symptoms, is pleased to announce a new partnership with Shannon Miller, the most decorated U.S. gymnast of all time and an ovarian cancer survivor. Effective immediately, the seven-time Olympic medalist and nine-time World...

redOrbit Staff & Wire Reports - Your Universe Online Researchers at the Mayo Clinic Cancer Center have identified new DNA sequences associated with breast and ovarian cancers that help reveal the underlying causes of these diseases so new prevention strategies can be devised. The findings appear in three studies in the journals PLoS Genetics and Nature Genetics. In the first study, published in the journal PLoS Genetics, researchers looked at variations across the genomes of...

HUNTSVILLE, Ala., March 19, 2013 /PRNewswire/ -- EGEN, Inc. today announced that it has recently initiated a Phase I clinical trial of its novel immunotherapy agent, EGEN-001, in combination with PEGylated liposomal Doxorubicin or Lipodox for the treatment of recurrent ovarian cancer. The EGEN-sponsored trial is conducted by a network of researchers led by Gynecologic Oncology Group (GOG) at member institutions under an agreement between the GOG and EGEN, Inc. Dr. Premal Thaker, of...

AUSTIN, Texas, March 13, 2013 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a molecular diagnostics company focused on gynecologic cancers and women's health, has appointed Thomas McLain as president and chief executive officer effective March 18, 2013. He succeeds Bruce Huebner, the company's interim chief executive officer, who will remain a director of the company and assist in the transition. McLain brings to Vermillion more than 20 years of experience in executive...

3 days of events helping Women with Journey through Cancer CHARLOTTE, N.C., March 13, 2013 /PRNewswire/ -- Andy Cohen, the ultimate celebrity insider and host of BRAVO's late-night, interactive talk show featuring guests from the world of entertainment, politics and pop culture, will perform in Charlotte for the first time Saturday, March 16, at the McGlohon Theater at 7 p.m. Cohen's performance is part of Shine for Women, a unique series of programs providing entertainment,...

Memorial Sloan-Kettering Cancer Center's national fundraising event has raised more than $31 million for rare cancer research since 2007 with founding partner, Equinox NEW YORK, March 11, 2013 /PRNewswire/ -- More than 12,000 cyclers gathered in ten cities across the country in February and early March to raise more than $13.8 million to support rare cancer research at Memorial Sloan-Kettering Cancer Center. The events took place at Equinox clubs in New York City; Los Angeles; San...

March 10 Event at SGO Annual Meeting to Feature Presentations by Noted Experts in Gynecologic Oncology and Molecular Genetics IRVING, Texas, March 8, 2013 /PRNewswire/ -- Caris Life Sciences(TM), a leading biosciences company focused on fulfilling the promise of personalized medicine, will sponsor an expert symposium, Integrating Next Generation Sequencing Into the Clinical Management of Gynecologic Cancers, at the 2013 Society of Gynecologic Oncology (SGO) Annual Meeting on Women's...